Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 4 1Phase 2 1

Status

Completed 2Terminated 1Recruiting 1Enrolling by invitation 1

Sponsor Class

OTHER 3INDUSTRY 2

Study Type

Interventional 4Observational 1

Sponsor

Cancer Type

Gastrointestinal 2Other hematologic neoplasm 1Lymphoid 1Breast 1

Conditions

Breast Neoplasms 461Neoplasms 378Carcinoma, Non-Small-Cell Lung 354Prostatic Neoplasms 294Colorectal Neoplasms 257Lung Neoplasms 225Multiple Myeloma 206Neoplasm Metastasis 164Pancreatic Neoplasms 156Leukemia, Myeloid, Acute 153Ovarian Neoplasms 136Squamous Cell Carcinoma of Head and Neck 130Melanoma 116Carcinoma, Renal Cell 103Stomach Neoplasms 102Carcinoma, Hepatocellular 100Recurrence 98Lymphoma 94Precursor Cell Lymphoblastic Leukemia-Lymphoma 92Head and Neck Neoplasms 91Lymphoma, Non-Hodgkin 86Glioblastoma 85Brain Neoplasms 84Hematologic Neoplasms 83Urinary Bladder Neoplasms 82Triple Negative Breast Neoplasms 81Endometrial Neoplasms 80Lymphoma, Large B-Cell, Diffuse 79Leukemia, Lymphocytic, Chronic, B-Cell 77Uterine Cervical Neoplasms 74

Interventions

obinutuzumab 1empagliflozin 1acalabrutinib 1Rituximab 1Carvedilol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Heart Failure × 30 days × Clear all
NCT07158450 2026-05-20

NOECHO

Skribe Medical

Enrolling by invitation
500 enrolled

Heart Failure, Cardiotoxicity

NCT06651970 2026-05-18

Acalabrutinib Monotherapy vs Investigator's Choice of Treatment in Patients With CL Leukaemia and Heart Failure

AstraZeneca

Phase 4 Recruiting
60 enrolled
LymphoidOther hematologic neoplasm

Heart Failure, Lymphatic Diseases, Leukemia, B-Cell

NCT01082419 2026-05-14

NARFI

University Hospital, Bordeaux

Phase NA Completed
109 enrolled
Gastrointestinal

Digestive System Diseases, Fibrosis, Heart Failure, Carcinoma, Hepatocellular, Liver Cirrhosis

NCT06844669 2026-05-13

HER2HEART-US: Prevention of Cardiotoxicity in Breast Cancer Patients Receiving HER2-directed Therapy

Washington University School of Medicine

Phase 2 Terminated
7 enrolled
Breast

Breast Neoplasms, Heart Failure, Cardiotoxicity

NCT05786482 2026-05-08

EMPOwer

University of Alberta

Phase NA Completed
825 enrolled
Gastrointestinal

Anxiety Disorders, Depression, Digestive System Diseases, Heart Failure, Liver Cirrhosis, Liver Cirrhosis, Biliary, Neoplasms, Renal Insufficiency, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡